This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Jul 15;216(2):283-284.

doi: 10.1093/infdis/jix293.

High Time to Start Human Immunodeficiency Virus Type 1-Infected Patients on Integrase Inhibitors in Sub-Saharan Africa

Emmanuel Ndashimye¹

Affiliations

PMID: 28838151
DOI: 10.1093/infdis/jix293

Comment

High Time to Start Human Immunodeficiency Virus Type 1-Infected Patients on Integrase Inhibitors in Sub-Saharan Africa

Emmanuel Ndashimye. J Infect Dis. 2017.

. 2017 Jul 15;216(2):283-284.

doi: 10.1093/infdis/jix293.

Author

Emmanuel Ndashimye¹

Affiliation

¹ Department of Microbiology and Immunology, Western University, London, Ontario,Canada.

PMID: 28838151
DOI: 10.1093/infdis/jix293

No abstract available

PubMed Disclaimer

Comment on

Prevalence of Antiretroviral Drug Resistance in Patients Who Are Not Responding to Protease Inhibitor-Based Treatment: Results From the First National Survey in South Africa.
Steegen K, Bronze M, Papathanasopoulos MA, van Zyl G, Goedhals D, Van Vuuren C, Macleod W, Sanne I, Stevens WS, Carmona SC. Steegen K, et al. J Infect Dis. 2016 Dec 15;214(12):1826-1830. doi: 10.1093/infdis/jiw491. Epub 2016 Oct 20. J Infect Dis. 2016. PMID: 27923946

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations